These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12927759)

  • 1. Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles.
    Lauckner J; Frey P; Geula C
    Neurobiol Aging; 2003 Oct; 24(6):767-76. PubMed ID: 12927759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
    Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
    Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.
    Guillozet-Bongaarts AL; Cahill ME; Cryns VL; Reynolds MR; Berry RW; Binder LI
    J Neurochem; 2006 May; 97(4):1005-14. PubMed ID: 16606369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
    Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
    J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites.
    Su JH; Cummings BJ; Cotman CW
    Neuroreport; 1994 Nov; 5(17):2358-62. PubMed ID: 7533559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
    Kondratick CM; Vandré DD
    J Neurochem; 1996 Dec; 67(6):2405-16. PubMed ID: 8931473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of calbindin-D28K is associated with the full range of tangle pathology within basal forebrain cholinergic neurons in Alzheimer's disease.
    Ahmadian SS; Rezvanian A; Peterson M; Weintraub S; Bigio EH; Mesulam MM; Geula C
    Neurobiol Aging; 2015 Dec; 36(12):3163-3170. PubMed ID: 26417681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau-tubulin kinase 1 expression, phosphorylation and co-localization with phospho-Ser422 tau in the Alzheimer's disease brain.
    Lund H; Cowburn RF; Gustafsson E; Strömberg K; Svensson A; Dahllund L; Malinowsky D; Sunnemark D
    Brain Pathol; 2013 Jul; 23(4):378-89. PubMed ID: 23088643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology.
    Maurage CA; Sergeant N; Ruchoux MM; Hauw JJ; Delacourte A
    Acta Neuropathol; 2003 Feb; 105(2):89-97. PubMed ID: 12536218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
    Combs B; Hamel C; Kanaan NM
    Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures.
    Rankin CA; Sun Q; Gamblin TC
    Neurobiol Dis; 2008 Sep; 31(3):368-77. PubMed ID: 18588978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of diffuse and fibrillar tangles in aging and early Alzheimer's disease.
    Uboga NV; Price JL
    Neurobiol Aging; 2000; 21(1):1-10. PubMed ID: 10794842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression.
    Regalado-Reyes M; Furcila D; Hernández F; Ávila J; DeFelipe J; León-Espinosa G
    J Alzheimers Dis; 2019; 69(1):277-288. PubMed ID: 30958368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.
    Mondragón-Rodríguez S; Perry G; Luna-Muñoz J; Acevedo-Aquino MC; Williams S
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):121-35. PubMed ID: 24033439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.
    Sheng JG; Mrak RE; Griffin WS
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):323-8. PubMed ID: 9600224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):158-67. PubMed ID: 17279001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
    Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia.
    Duong T; De Rosa MJ; Poukens V; Vinters HV; Fisher RS
    Acta Neuropathol; 1994; 87(5):493-503. PubMed ID: 8059602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains.
    Pearson AG; Byrne UT; MacGibbon GA; Faull RL; Dragunow M
    Neurosci Lett; 2006 May; 398(3):246-50. PubMed ID: 16481106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.